Growth Metrics

Tandem Diabetes Care (TNDM) Finished Goods (2016 - 2019)

Historic Finished Goods for Tandem Diabetes Care (TNDM) over the last 6 years, with Q1 2019 value amounting to $9.7 million.

  • Tandem Diabetes Care's Finished Goods fell 2148.42% to $9.7 million in Q1 2019 from the same period last year, while for Mar 2019 it was $9.7 million, marking a year-over-year decrease of 2148.42%. This contributed to the annual value of $10.6 million for FY2018, which is 1780.91% down from last year.
  • Per Tandem Diabetes Care's latest filing, its Finished Goods stood at $9.7 million for Q1 2019, which was down 2148.42% from $10.6 million recorded in Q4 2018.
  • In the past 5 years, Tandem Diabetes Care's Finished Goods registered a high of $14.4 million during Q3 2017, and its lowest value of $2.9 million during Q2 2015.
  • Its 5-year average for Finished Goods is $8.5 million, with a median of $9.1 million in 2016.
  • In the last 5 years, Tandem Diabetes Care's Finished Goods surged by 14549.96% in 2016 and then plummeted by 2148.42% in 2019.
  • Over the past 5 years, Tandem Diabetes Care's Finished Goods (Quarter) stood at $3.5 million in 2015, then soared by 109.57% to $7.4 million in 2016, then skyrocketed by 73.1% to $12.9 million in 2017, then dropped by 17.81% to $10.6 million in 2018, then dropped by 8.36% to $9.7 million in 2019.
  • Its Finished Goods stands at $9.7 million for Q1 2019, versus $10.6 million for Q4 2018 and $11.3 million for Q3 2018.